Clearstead Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$677K Buy
14,055
+101
+0.7% +$4.71K 0.01% 639
2025
Q4
$676K Buy
13,954
+1,485
+12% +$73.6K 0.01% 574
2025
Q3
$589K Sell
12,469
-6,448
-34% -$311K 0.01% 583
2025
Q2
$914K Buy
18,917
+551
+3% +$28.2K 0.01% 468
2025
Q1
$1.02M Sell
18,366
-680
-4% -$36.8K 0.02% 406
2024
Q4
$919K Sell
19,046
-2,511
-12% -$128K 0.01% 427
2024
Q3
$1.24M Sell
21,557
-22
-0.1% -$1.19K 0.02% 382
2024
Q2
$1.05M Buy
21,579
+20,714
+2,395% +$999K 0.02% 385
2024
Q1
$43.4K Sell
865
-120
-12% -$5.86K ﹤0.01% 799
2023
Q4
$49K Sell
985
-145
-13% -$7.09K ﹤0.01% 740
2023
Q3
$60.6K Buy
1,130
+290
+35% +$15.5K ﹤0.01% 850
2023
Q2
$45.3K Sell
840
-125
-13% -$6.73K ﹤0.01% 744
2023
Q1
$52.5K Hold
965
﹤0.01% 656
2022
Q4
$46.7K Buy
965
+256
+36% +$11.2K ﹤0.01% 634
2022
Q3
$27K Sell
709
-80
-10% -$3.56K ﹤0.01% 719
2022
Q2
$39K Buy
789
+80
+11% +$4.25K ﹤0.01% 667
2022
Q1
$36K Hold
709
﹤0.01% 744
2021
Q4
$36K Buy
709
+325
+85% +$16.1K ﹤0.01% 714
2021
Q3
$19K Sell
384
-162
-30% -$8.24K ﹤0.01% 836
2021
Q2
$29K Buy
546
+62
+13% +$3.23K ﹤0.01% 644
2021
Q1
$24K Hold
484
﹤0.01% 643
2020
Q4
$24K Buy
484
+164
+51% +$8.09K ﹤0.01% 604
2020
Q3
$16K Hold
320
﹤0.01% 613
2020
Q2
$16K Hold
320
﹤0.01% 550
2020
Q1
$14K Buy
+320
New +$15.3K ﹤0.01% 544

Other funds holding SNY

Clearstead Advisors's SNY Position: Q1 2026 in Review

Clearstead Advisors increased its Sanofi (SNY) stake by 0.72% in Q1 2026, buying an estimated $4.71K and bringing the position to 14,055 shares worth $677K. The position accounts for 0.01% of the portfolio, ranked #639.

Clearstead Advisors first reported a position in SNY in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.24M in Q3 2024. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Clearstead Advisors held 14,055 shares of Sanofi worth $677K as of Q1 2026.
  • Clearstead Advisors bought 101 Sanofi shares in Q1 2026, an estimated $4.71K.
  • Sanofi made up 0.01% of Clearstead Advisors's portfolio in Q1 2026, its #639 holding.
  • Clearstead Advisors first reported a position in Sanofi in Q1 2020 and has held it in 25 quarters since.
  • Clearstead Advisors's Sanofi position peaked at $1.24M in Q3 2024.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.